CorMedix Inc. Reports Second Quarter 2016 Financial Results and Provides Business Updates

CorMedix Secures First Research Collaboration in the Medical Device Space with Luna Innovations Inc.

SNNLive spoke with Randy Milby, CEO of CorMedix, Inc. at the Marcum MicroCap Conference 2016 in New York City, NY

CorMedix Inc. Announces Publication of Pharmacoeconomic Study that Highlights the Clinical and Economic Need for Products that Can Prevent Catheter-Related Bloodstream Infections

CorMedix Inc. Presented Post-Market Clinical Utility Data from Neutrolin(R) Usage Monitoring Program at 53rd Joint Congress of the European Renal Association - European Dialysis and Transplant Association

CorMedix Rings the NYSE Opening Bell

CorMedix Inc. Announces Publication of New Pharmacoeconomic Data Demonstrating Cost of Catheter-Related Infections at the ISPOR 21st Annual International Meeting

CorMedix Inc. Reports First Quarter 2016 Financial Results

CorMedix Inc. Announces Agreement with NanoProteagen for its Proprietary Nanoparticle Technology, NanoPro™, in combination with CRMD-005 for Pediatric Neuroblastoma

CorMedix Inc. to Report First Quarter 2016 Financial Results

CorMedix Announces Publication of Neutrolin® Data to be Presented at the 1st Gulf Congress of Clinical Microbiology and Infectious Diseases

CorMedix Appoints Myron Kaplan to Board of Directors

CorMedix to Present Data from Landmark Post-Approval Surveillance Study at National Kidney Foundation® 2016 Spring Clinical Meetings

CorMedix to Present at the 1st Gulf Congress of Clinical Microbiology and Infectious Diseases

CorMedix Inc. to Present Post-Market Clinical Utility Data from Neutrolin® Usage Monitoring Program on May 23, 2016

CorMedix Proprietary Antimicrobial Technology Featured at the ASAPS Aesthetic Meeting 2016

CorMedix Inc. to be Featured on Panel at FBR & Co. Healthcare Series Event Focused on Infectious Diseases

CorMedix Fourth Quarter and Year End Review Conference Call Audio

CorMedix Inc. to Present at 28th Annual ROTH Conference

CorMedix Inc. 2015 Year in Review and 2016 Objectives

CorMedix to Present at Biotech Showcase™ 2016